PharmaShots | Incisive News in 3 Shots

Subscribe Now

PD-L1-High Non-Small Cell Lung Cancer

Genentech's Tiragolumab + Tecentriq Receive the US FDA's Breakthrough Therapy Designation for PD-L1-High Non-Small Cell Lung Cancer

Genentech's Tiragolumab + Tecentriq Receive the US FDA's Breakthrough Therapy Designation for PD-L1-High Non-Small Cell Lung Cance...

January 5, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us